Tubal Ligation and Risk of Endometrial Cancer: Findings from the Women's Health Initiative

International Journal of Gynecological Cancer

Volumn 26, Issue 3, 2016, Pages 464-471

  Winer, Ira ^a   Lehman, Amy ^b   Wactawski Wende, Jean ^c   Robinson, Randal ^d   Simon, Michael ^e   Cote, Michele ^f  

^a WAYNE STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^e WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f KARMANOS CANCER INSTITUTE   (United States)

Author keywords

Endometrial cancer; Tubal ligation; Women's Health Initiative

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; AGED; ARTICLE; BILATERAL TUBAL LIGATION; BIRTH CONTROL; CANCER RISK; COHORT ANALYSIS; DEMOGRAPHY; DIABETES MELLITUS; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; ORAL CONTRACEPTIVE USE; PARITY; PRIORITY JOURNAL; SMOKING; UTERINE TUBE LIGATION; ADVERSE EFFECTS; CANCER STAGING; ENDOMETRIAL NEOPLASMS; INCIDENCE; POSTMENOPAUSE; PROGNOSIS; RISK FACTOR; UNITED STATES; UTERINE TUBE STERILIZATION; VERY ELDERLY; WOMEN'S HEALTH;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MIDDLE AGED; NEOPLASM STAGING; POSTMENOPAUSE; PROGNOSIS; RISK FACTORS; STERILIZATION, TUBAL; UNITED STATES; WOMEN'S HEALTH;

EID: 84962302036     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0000000000000651     Document Type: Article

References (27)

1. Mosher WD, Martinez GM, Chandra A, Use of contraception and use of family planning services in the United States: 1982-2002. Adv Data. 2004; 350: 1-36.
2. Siegel R, Ma J, Zou Z, Cancer statistics, 2014. CA Cancer J Clin. 2014; 64: 9-29.
3. Tung KH, Goodman MT, Wu AH, Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case-control study. Am J Epidemiol. 2003; 158: 629-638.
4. Massuger L, Roelofsen T, Ham M, The origin of serous ovarian cancer may be found in the uterus: a novel hypothesis. Med Hypotheses. 2010; 74: 859-861.
5. Cibula D, Widschwendter M, Májek O, Tubal ligation and the risk of ovarian cancer: review and meta-analysis. Hum Reprod Update. 2011; 17: 55-67.
6. Rosenblatt K, Thomas D,. Association between tubal ligation and endometrial cancer. Int J Cancer. 1997; 71: 129-130.
7. Lacey JV Jr, Brinton LA, Mortel R, Tubal sterilization and risk of cancer of the endometrium. Gynecol Oncol. 2000; 79: 482-484.
8. Kjaer SK, Mellemkjaer L, Brinton LA, Tubal sterilization and risk of ovarian, endometrial and cervical cancer. A Danish population-based follow-up study of more than 65 000 sterilized women. Int J Epidemiol. 2004; 33: 596-602.
9. Castellsague X, Thompson WD, Dubrow R,. Tubal sterilization and the risk of endometrial cancer. Int J Cancer. 1996; 65: 607-612.
10. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials. 1998; 19: 61-109.
11. Langer RD, White E, Lewis CE, The Women's Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol. 2003; 13 (suppl 9): S107-S121.
12. Ritenbaugh C, Patterson RE, Chlebowski RT, The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Ann Epidemiol. 2003; 13 (suppl 9): S87-S97.
13. Anderson GL, Limacher M, Assaf AR, Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA. 2004; 291: 1701-1712.
14. Thiebaut AC, Benichou J,. Choice of time-scale in Cox's model analysis of epidemiologic cohort data: a simulation study. Stat Med. 2004; 23: 3803-3820.
15. Thiébaut R, Jacqmin-Gadda H,. Mixed models for longitudinal left-censored repeated measures. Comput Methods Programs Biomed. 2004; 74: 255-260.
16. Ayeni TA, Bakkum-Gamez JN, Mariani A, Impact of tubal ligation on routes of dissemination and overall survival in uterine serous carcinoma. Gynecol Oncol. 2013; 128: 71-76.
17. Felix AS, Brinton LA, McMeekin DS, Relationships of tubal ligation to endometrial carcinoma stage and mortality in the NRG oncology/gynecologic oncology group 210 trial. J Natl Cancer Inst. 2015; 107 (10): djv158.
18. Kelekci S, Yilmaz B, Yakut Y, Hormonal and ovarian stromal blood supply changes after laparoscopic tubal sterilization: a prospective controlled study. Contraception. 2006; 73: 279-283.
19. Kelekci S, Yilmaz B, Yasar L, Ovarian reserve and ovarian stromal blood supply after tubal ligation by the Pomeroy technique: comparison with controls. Gynecol Endocrinol. 2005; 20: 279-283.
20. Nelson DB, Sammel MD, Freeman EW, Tubal ligation does not affect hormonal changes during the early menopausal transition. Contraception. 2005; 71: 104-110.
21. Wu E, Xiao B, Yan W, Hormonal profile of the menstrual cycle in Chinese women after tubal sterilization. Contraception. 1992; 45: 583-593.
22. Pathiraja P, Dhar S, Haldar K,. Serous endometrial intraepithelial carcinoma: a case series and literature review. Cancer Manag Res. 2013; 5: 117-122.
23. Jia L, Liu Y, Yi X, Endometrial glandular dysplasia with frequent p53 gene mutation: a genetic evidence supporting its precancer nature for endometrial serous carcinoma. Clin Cancer Res. 2008; 14: 2263-2269.
24. Zheng W, Schwartz PE,. Serous EIC as an early form of uterine papillary serous carcinoma: recent progress in understanding its pathogenesis and current opinions regarding pathologic and clinical management. Gynecol Oncol. 2005; 96: 579-582.
25. Tashiro H, Isacson C, Levine R, p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis. Am J Pathol. 1997; 150: 177-185.
26. Sherman ME, Bur ME, Kurman RJ,. p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis. Hum Pathol. 1995; 26: 1268-1274.
27. Ambros RA, Sherman ME, Zahn CM, Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation. Hum Pathol. 1995; 26: 1260-1267.